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The derivatives of the neural crest are regionally speci®ed with respect to the anterior±posterior axis of the avian embryo.
We have shown previously that young Hensen's node can act in vitro to regulate the expression of certain region-speci®c
phenotypes in trunk neural crest cells. To study potential factors acting on the neural crest, we have generated an immortal-
ized cell line from young Hensen's node. Here we show that a factor produced by these cells stimulates the expression of
two cranial-speci®c phenotypes (®bronectin and smooth muscle actin) in trunk neural crest cells and decreases their
expression of a trunk-speci®c phenotype (melanin). The active factor is a secreted protein with a molecular weight 30
kDa. Clonal studies suggest that the factor acts by changing the phenotypic fates of individual neural crest cells, rather
than by selective effects on cell proliferation or survival. Previous work has shown that TGF-bs can mimic the effects of
Hensen's node cells on neural crest differentiation. Results from the present study suggest that the factor in the conditioned
medium of the immortalized node cell line is not a TGF-b isoform. However, the cranial phenotype-inducing activity of
the conditioned medium factor requires the presence of neural crest cell-derived TGF-bs. q 1996 Academic Press, Inc.
INTRODUCTION tissue (Raven, 1931; Hammond and Yntema, 1964; Le Lievre
and Le Douarin, 1975), but instead generates large numbers
The neural crest is a population of cells arising at the of melanocytes. The kinds of autonomic neurons produced
junction between the neural plate and the epidermis. As by the cranial and trunk regions of the neural crest also
the neural plate closes to form the neural tube, the cells of differ. The cranial region produces parasympathetic and en-
the neural crest break away from the neuroepithelium and teric neurons, whereas the trunk region produces sympa-
migrate into the periphery. They populate a number of char- thetic neurons and adrenal medullary cells (reviewed in Le
acteristic sites and generate a large assortment of cell types, Douarin, 1982).
including neurons and Schwann cells of the peripheral ner- Regional differences in neural crest cell fates appear to
vous system, melanocytes of the skin, and ectomesenchy- be determined in part by signals that act on the cells after
mal tissues of the head (reviewed in Horstadius, 1950; Le they migrate away from the neural tube. The importance
Douarin, 1982). of such signals has been demonstrated most clearly for the
A distinguishing feature of neural crest development is case of A-P differences in neuronal fates. It has been shown,
that different anterior-posterior (A-P) regions of the neural for example, that when cranial neural crest cells are trans-
crest normally generate different sets of derivatives. The planted into the trunk region, some of the cells differentiate
cranial region produces ectomesenchymal tissues, includ- into sympathetic neurons and adrenal medullary cells (Le
ing connective tissue, cartilage, smooth muscle, and bone. Douarin and Teillet, 1974; Le Lievre et al., 1980). Similarly,
The trunk region produces little or no ectomesenchymal trunk neural crest cells can produce parasympathetic and
enteric neurons following transplantation to more cranial
levels (Le Douarin et al., 1975; Kirby, 1989).1 To whom correspondence should be addressed at Department
In contrast, certain A-P differences in nonneuronal fatesof Biological Structure and Function, SD, Oregon Health Sciences
appear to be determined prior to neural crest cell migration.University, 611 SW Campus Dr., Portland, OR 97201. Fax: 503-
494-4666. E-mail: leblancg@ohsu.edu. This is true, for example, of A-P differences in the chondro-
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ration in trypsin (0.5% in 0.02% EDTA; ICN). The cells were thengenic potential of the neural crest. Trunk neural crest cells
pelleted at 800 rpm in a Beckman tabletop centrifuge and resus-transplanted into the cranial region fail to produce cartilage
pended in enriched medium [minimal essential medium (MEM;or bone, which are normal derivatives of the cranial neural
obtained from GIBCO) enriched with 15% horse serum (GIBCO),crest (Raven, 1931; Nakamura and Ayer-Le Lievre, 1982).
10% chick embryo extract, and 0.1 mg/ml gentamycin (Sigma); theConversely, cranial neural crest cells transplanted into the
chick embryo extract was prepared as described in Howard and
trunk region form ectopic cartilage, a derivative not nor- Bronner-Fraser, 1985]. The cells were plated on ®bronectin-coated
mally produced by trunk neural crest (Le Douarin and Teil- dishes for approximately 12 hr before transfection and fed with
let, 1974). Hence, there must be mechanisms that act to fresh medium immediately before transfection.
generate A-P differences among neural crest cells before the A construct containing the v-myc oncogene was obtained from
ATCC (Vennstrom et al., 1981). A 4.4-kb KpnI±EcoRI fragmentcells migrate away from the neural tube. Consistent with
was subcloned into an expression vector driven by an Rous sarcomathis idea, certain homeobox genes are known to be ex-
virus (RSV) promoter (a gift from Dr. Eileen Adamson), to generatepressed in a region-speci®c manner in premigratory neural
RSV-myc. Twenty micrograms of the RSV-myc was suspended increst cells (reviewed in Keynes and Krumlauf, 1994).
960 ml of 11 Hepes-buffered saline (0.14 M NaCl, 0.025 M Hepes,The A-P regionalization of the neural crest may be di-
0.75 mM Na2HPO4, with the 101 stock having a pH of 7.05). Therected by mechanisms similar to those that regionalize the
DNA was precipitated by adding 40 ml of 2.5 M CaCl2 dropwiseneural tube. In avians, the A-P regionalization of the neural while vortexing vigorously. Precipitate (250 ml) was applied to each
tube is thought to be directed by signals emanating from 35-mm dish of cells for up to 6 hr. The cells were washed three
prospective midline mesodermal cells, during or soon after times in phosphate-buffered saline (PBS) and fed with enriched me-
their ingression through Hensen's node (for recent reviews, dium every 2 days.
Rapidly growing cells, which began to appear after 7 days, weresee Ruiz i Altaba, 1994; Stern, 1994). Transplantation stud-
cloned by trypsinization within a cloning cylinder. Cells that sur-ies have shown that Hensen's node explants can induce
vived passage and continued to proliferate rapidly were consideredneural tissue from the ectoderm of host embryos (Wad-
immortalized. Subsequent RNase protection assays veri®ed the ex-dington, 1932) and that the regional character of the induced
pression of the oncogene in these cells (see Results). The resultingneural tissue depends on the age of the transplanted node.
Hensen's node cell line was named HN-1. A control cell line,Nodes obtained from younger embryos (stages 2±4; Ham-
named Ep694, was generated from the anterior epiblast of stage 3/
burger and Hamilton, 1951) induce anterior neural tissue, to 4 quail embryos using techniques identical to those described
whereas nodes obtained from older embryos induce poste- above.
rior neural tissue (Tsung et al., 1965; Vakaet, 1965; Gallera,
1970; Storey et al., 1992).
We have previously used in vitro experiments to ask RNase Protection Assays
whether Hensen's node also regulates the expression of re-
RNase protection was performed essentially as described in (Au-gion-speci®c phenotypes in developing neural crest cells
subel et al., 1989). The probe was made from a 270-bp PstI±SphI(Leblanc and Holbert, 1996). We found that trunk neural
fragment overlapping the 3* end of the v-myc and the viral envelop
crest cells cocultured with young Hensen's node increased portions of the expression vector construct. Poly(A)/ RNA was iso-
their expression of cranial-speci®c markers, including ®- lated as described previously (Chomczynski and Sacchi, 1987), us-
bronectin and smooth muscle actin, and decreased their ing a TRI Reagent kit (Molecular Research Center, Inc.). Two mi-
expression of a trunk-speci®c marker, melanin. These re- crograms of poly(A)/ RNA was hybridized overnight with 1 1 105
cpm of the radioactive v-myc probe. After treatment with RNasesults suggest that interactions with Hensen's node may play
and proteinase K, protected fragments were run on a sequencinga role in determining regional differences in neural crest
gel (8 M urea, 6% acrylamide, 0.51 Tris, borate, EDTA). The bandscell fates. Here we show that immortalized Hensen's node
were visualized by autoradiography.cells have effects on trunk neural crest cell differentiation
similar to those observed for the primary cells. Using condi-
tioned medium from this immortalized cell line, we provide
Neural Crest Culturesan initial characterization of the activity responsible for
regulating region-speci®c phenotypes in neural crest cul- Explants of trunk and cranial neural crest were obtained as de-
scribed previously (Cohen, 1977; Leblanc, 1994) from stage 14 andtures.
stage 9 embryos, respectively. The explants were plated onto ®bro-
nectin-coated dishes and fed with enriched medium. After 1 day
in vitro, the cultures were scraped free of non-neural crest cells
MATERIALS AND METHODS using a tungsten needle. The neural crest cells were then dissoci-
ated by treatment with 5 mM EDTA, spun down, and resuspended
in enriched medium. The cells were plated onto Millipore ®ltersImmortalization Procedures
(for trans®lter cocultures) or into 96-well plates.
Trans®lter cocultures were performed as previously describedHensen's node explants were removed from stage 3/ to 4 quail
(Coturnix coturnix japonica) embryos as described previously (Leblanc and Holbert, 1996). Brie¯y, silicone vacuum grease was
used to create opposing 3-mm wells on each side of a black HA(Leblanc and Holbert, 1996). Explants from 25 to 30 embryos were
used for most experiments. The explants were dissociated by tritu- Millipore ®lter (0.45-mm pore size). Approximately 5 1 104 HN-
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1 cells were plated within the grease ring on one side of the ®lter. to chicken smooth muscle actin was obtained from Sigma, and the
HNK-1 antibody was obtained from Becton±Dickenson.After the cells adhered, the ®lters were inverted, and approxi-
mately the same number of neural crest cells was plated within In some experiments, the percentages of neural crest cells ex-
pressing ®bronectin, smooth muscle actin, and melanin were deter-the other ring.
mined as follows. After growing for 6 days in 96-well plates, the
cells were dissociated and replated onto Primaria culture dishes
(Falcon) at low density. The next day, cells were ®xed and double-ELISAs and Immunoclearance
stained with a rabbit anti-chick ®bronectin antiserum and a mouse
anti-chick smooth muscle actin antiserum as described previouslyConditioned medium from the HN-1 and Ep694 cell lines was
(Leblanc et al., 1995). The cells were also stained with 4*, 6-diamid-collected as follows. Cells were plated at approximately 40% con-
ino-2-phenylindole (DAPI) to visualize cell nuclei. Melanin gran-¯uence. Medium was collected 2 days later, after the cells had
ules were visualized under bright-®eld optics. At least 600 cellsreached 90±100% con¯uence. Conditioned medium (CM) was
from each culture were counted.pushed through a 0.22-mm syringe ®lter to remove any cells, ali-
quoted, and frozen at 0707C.
One-day-old cultures of neural crest cells were dissociated as
described above and plated into 96-well plates at a density of ap-
Clonal Culturesproximately 1.5 1 104 cells per well. The cells were fed 50% CM
from either the HN-1 or Ep694 cell lines (diluted in fresh enriched
Clonal cultures were made by dissociating neural crest culturesmedium). ELISA assays were performed after 5 days in vitro. The
after 1 day in vitro and resuspending the cells at a concentrationcells were ®xed and incubated with a mouse monoclonal antibody
of 1 cell per 10 ml medium. Ten-microliter aliquots of this cellto chick ®bronectin as described previously (Leblanc et al., 1995).
suspension were spotted into the wells of a 96-well plate. The spotsThe cells were then incubated for an hour at room temperature
were examined for single cells before feeding. The resulting cloneswith an alkaline phosphatase-conjugated secondary antibody (Pro-
were cultured for 7 days in either 50% HN-1 or Ep694 CM (dilutedmega) diluted 1:500 in blocking solution (10% horse serum, 0.2%
in enriched medium). The plates were inspected daily to track theTriton X-100, and 0.1% sodium azide in PBS). After addition of the
progress of colonies derived from single cells. The clones were thensubstrate solution (p-nitrophenyl phosphate, 1 mg/ml in 100 mM
trypsinized and replated onto Primaria dishes for 2 days prior toTris containing 100 mM NaCl and 5 mM MgCl2), the absorbance
®xation and stained with DAPI and the rabbit antiserum to ®bro-at 405 nm was read on a kinetic microplate reader. Control values
nectin. Melanocytes, ®bronectin-positive cells, and total cells werefor wells containing medium without cells and for wells containing
counted under the 401 objective of an Olympus epi¯uorescencecells incubated without primary antibody were subtracted from the
microscope.experimental values. After performing the ELISA, the cultures were
rinsed extensively in PBS and total protein per well was measured
using a protein quanti®cation kit (Pierce).
In the immunoclearance experiments, HN-1 CM was incubated
overnight with 20 mg/ml of either a pan-speci®c rabbit antiserum RESULTS
to TGF-b (R&D Systems) or a control antiserum (anti-desmin;
Chemicon). The TGF-b antiserum recognized a single major pro-
tein band in Western blots of both neural crest cell and HN-1 cell- Immortalization of Cells from Hensen's Node
conditioned medium collected under serum-free conditions; the
molecular weight of this band corresponded to that of the latent We were interested in characterizing Hensen's node-de-
form of TGF-b. As a control for the ef®ciency of the immunoclear- rived factors that stimulate the expression of cranial-spe-
ance, TGF-b1 (puri®ed from human platelets; a gift from Drs. Karin
ci®c phenotypes in neural crest cultures. To this end, weRodland and Bruce Magun) was added to Ep694 CM at a ®nal con-
generated an immortalized cell line from Hensen's node.centration of 10 ng/ml. The medium was then incubated overnight
Hensen's node cells were obtained from stage 3/ to 4 quailwith agarose beads conjugated to anti-rabbit IgG (Sigma). Twenty-
embryos and transfected with a v-myc expression vectorfour hours later, the beads were spun down and the cleared medium
was used at a 50% dilution in fresh enriched medium. In direct driven by an RSV promoter. (The v-myc gene has been used
blocking experiments, 20 mg/ml of TGF-b or desmin antiserum was successfully by a number of investigators to generate im-
added to 50% HN-1 CM or 50% Ep694 CM supplemented with 5 mortalized cell lines from both rodent and avian cells; see
ng/ml TGF-b1. In these experiments, the medium was not cleared for example, Land et al., 1983; Palmieri et al., 1983; Ryder
and the neural crest cells were directly exposed to the antisera. et al., 1990). The resulting cell line, called HN-1, grew rap-
idly to con¯uence and was passaged as many as 10 times
without any obvious changes in growth rate, morphology,
Immunocytochemistry or bioactivity (see below). The nontransfected primary cells,
in contrast, did not proliferate after passage. The HN-1 cells
Immunocytochemistry was performed as described previously
were normally maintained in enriched culture medium,(Leblanc et al., 1995). The following mouse monoclonal antibodies
containing 15% horse serum and 10% embryo extract.were obtained from Developmental Studies Hybridoma Bank:
However, the cells could also be maintained under serum-NOT1, IXF1, 12/101, 5e (which recognizes NCAM), and B3/D6
free conditions for up to 4 days before becoming quiescent.(which recognizes chick ®bronectin). The rabbit antiserum to chick
®bronectin was obtained from Chemicon, the mouse monoclonal The HN-1 cells showed high expression of the v-myc
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Nicolet, 1971; Bellairs, 1986). The HN-1 cells resembled the
latter cell population in that they exhibited a mesenchymal
morphology (Fig. 1b). In addition, the HN-1 cells uniformly
expressed high levels of ®bronectin immunoreactivity (a
marker expressed by most mesodermal and ectomesenchy-
mal cells), but lacked the IXF1 antigen (an ectoderm/endo-
derm marker). Neither the primary cells nor the HN-1 cells
exhibited markers characteristic of more fully differentiated
mesodermal derivatives of the node, such as notochord or
skeletal muscle.
None of the HN-1 cells expressed the HNK-1 epitope,
which is normally expressed by a subpopulation of the pri-
mary cells in vivo (Canning and Stern, 1988) and in culture.
Thus, it is possible that the HN-1 cells arose from a HNK-
10 subpopulation of node cells. Alternatively, increased pro-
liferation or other effects of immortalization may have al-
tered the repertoire of cell-surface proteins expressed by the
cells.
Coculture with HN-1 Cells Stimulates Fibronectin
Expression and Inhibits Melanin Expression in
Trunk Neural Crest Cultures
To test whether the HN-1 cells had the same effects on
trunk neural crest differentiation as primary young
Hensen's node cells, we performed trans®lter coculture
assays like those described previously (Leblanc and Holbert,
1996). Trunk neural crest and HN-1 cells were cocultured
on opposite sides of a Millipore ®lter. After 5 days, the
cultures were ®xed and the trunk neural crest cells were
examined for ®bronectin immunoreactivity and melanin
expression. As we have observed previously, trunk neural
crest cells cultured alone developed negligible amounts of
FN immunoreactivity (Fig. 2a). In contrast, trunk neural
crest cells cocultured with HN-1 cells developed dense ma-FIG. 1. Immortalized cells from Hensen's node. (a) RNase protec-
trices of FN-immunoreactive ®brils (Fig. 2b). This stimula-tion assay demonstrating expression of the v-myc oncogene by the
tion of FN expression was accompanied by an equally dra-HN-1 (lane 3) and Ep694 (lane 4) cell lines. The protected band run
matic inhibition of melanin expression (compare Figs. 2cat 90 bases (marked by the arrowhead). The other lanes include a
and 2d). Thus, the effects of HN-1 cells on both ®bronectin100-bp RNA ladder (M), undigested probe (lane 1), and a tRNA
negative control (lane 2). (b) HN-1 cells shown under phase. Origi- and melanin expression in trunk neural crest cultures were
nal magni®cation, 1261. similar to those previously reported for primary Hensen's
node cells (Leblanc and Holbert, 1996).
Effects of HN-1 Cell-Conditioned Medium onRNA as measured by RNase protection (Fig. 1a). High levels
Trunk Neural Crest Cell Differentiationof v-myc expression were also seen in an epiblast cell line,
Ep694, which was generated to serve as a control for condi- The fact that the HN-1 cells could act across a Millipore
®lter suggested that the activity produced by the cells wastioned medium experiments. The v-myc probe gave a 90-
base protected fragment for both immortalized lines, but diffusible. To test this idea further, we examined the effect
of HN-1 cell-conditioned medium (CM) on trunk neuralnot for primary cells (data for the latter not shown).
We examined the HN-1 cells for antigens that are nor- crest cultures. Fibronectin expression in the cultures was
quantitated using an ELISA protocol (Leblanc et al., 1995).mally expressed by primary Hensen's node cells and/or their
derivatives. In situ, Hensen's node contains a super®cial In the experiment shown in Fig. 3A, growth in 50% HN-1
CM caused a 3.8-fold increase in ®bronectin expression bylayer of epiblast cells (which give rise to epidermis and neu-
ral tissue) and a deeper layer of migrating mesenchymal trunk neural crest. The levels of ®bronectin expression in
trunk neural crest cultures treated with HN-1 CM werecells (which form mesoderm and endoderm) (reviewed in
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FIG. 2. Effect of the HN-1 cells on ®bronectin and melanin expression in trunk neural crest cultures. (a and b) Fibronectin immunoreactiv-
ity in trunk neural crest cultures grown alone (a) or trans®lter to HN-1 cells (b) for 5 days in vitro. Original magni®cation, 1301. (c and
d) The same cultures viewed under bright®eld at lower magni®cation (181) to visualize melanin.
comparable to those normally seen in cultures of untreated fects of medium conditioned by an epiblast cell line (Ep694
CM). Ep694 CM had a small, but signi®cant, stimulatorycranial neural crest. The stimulation of ®bronectin expres-
sion produced by different batches of CM ranged from 2.5- effect on ®bronectin levels relative to undiluted fresh me-
dium (EE) (Fig. 3B). This effect of the Ep694 CM might beto 8-fold relative to control; there was much less variability
in the fold stimulation produced by a given batch of CM. due to depletion of a factor in the medium that inhibits
®bronectin expression. Alternatively, it is possible that theNote that the fold stimulation of ®bronectin levels by
HN-1 CM as measured by ELISA is lower than one might Ep694 cells secrete low levels of a factor that stimulates
®bronectin expression. Importantly, however, the effect ofexpect based on the immuno¯uorescence results obtained
with intact cells in trans®lter experiments (e.g., the results Ep694 CM on ®bronectin expression was much smaller
than that seen with HN-1 CM. Thus, while depletion ofshown in Fig. 2). This difference re¯ects the lower signal
to background ratio of the ELISA versus the immuno¯uo- medium factors by the HN-1 cells may have some effect on
neural crest cell differentiation, it cannot account for morerescence detection method rather than differences in the
activity of intact cells versus CM; we see similar differences than a small part of the effect of HN-1 CM.
Total protein levels in HN-1 CM-treated cultures werein the results provided by the two methods when comparing
®bronectin levels in cranial versus trunk cultures. The about 20% lower than those in cultures grown in fresh me-
dium, but did not differ from those in cultures grown inELISA method is therefore likely to underestimate the fold
stimulation of ®bronectin expression elicited by any partic- EpCM. Thus, HN-1 CM may have some negative effects on
cell survival and/or cell proliferation in neural crest culturesular culture condition; nonetheless, it is useful for compar-
ing the effects of various culture conditions on ®bronectin relative to fresh medium, but these effects cannot account
for the phenotypic changes produced by HN-1 CM. (Thisexpression.
Compared to fresh medium, HN-1 CM is likely to be conclusion is borne out by the results of clonal analyses;
see below).depleted of nutrients. To ensure that the effects of HN-1
cell CM on trunk neural crest cell differentiation were not We also examined the effects of HN-1 CM on the percent-
ages of cells in trunk neural crest cultures that expressedan artifact of nutrient depletion, we also examined the ef-
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step serves to increase the levels of ®bronectin immunore-
activity within individual cells and thereby makes it possi-
ble to determine which cells are expressing ®bronectin
(Leblanc, 1994). Using this method, we found that treat-
ment with 50% HN-1 CM produced a 3-fold increase in the
percentage of cells expressing ®bronectin, a 2.8-fold increase
in the percentage expressing smooth muscle actin, and a
3.5-fold decrease in the percentage expressing melanin (Fig.
4). Again, these results are similar to those previously ob-
tained with primary Hensen's node cells (Leblanc and Hol-
bert, 1996). (Note: A disadvantage of the replating step is
that it appears to upregulate ®bronectin expression in con-
trol trunk cultures to a greater extent than it does in HN-
1 CM-treated trunk cultures. Hence, as was true for the
ELISA, this method probably underestimates the increase
in ®bronectin expression produced by HN-1 CM. The re-
plating step has no obvious effect on the expression of
smooth muscle actin or melanin.)
To learn how long an exposure to HN-1 CM was required
to stimulate ®bronectin expression in trunk neural crest
cultures, the cultures were treated with CM for Days 0±
1, 0±3, or 0±5. All cultures were assayed for ®bronectin
expression on Day 5. As shown in Fig. 5, a 3-day exposure
to CM was suf®cient to elicit a signi®cant increase in ®-
bronectin expression, but a 1-day exposure was not.
FIG. 3. Stimulation of ®bronectin immunoreactivity (FN-IR) in
trunk neural crest cultures by HN-1 cell-conditioned medium (HN-
1 CM). (A) Cranial neural crest, untreated trunk neural crest, and
HN-1 CM-treated trunk neural crest were cultured for 6 days in
96-well plates and assayed for ®bronectin immunoreactivity by
ELISA. (B) Comparison of levels of ®bronectin immunoreactivity
in trunk neural crest cultures grown in 100% enriched medium
(EE), 50% HN-1 CM, or 50% Ep694 CM (Ep CM). The bars show
the means { SEM of three determinations. Asterisks indicate val-
ues that differed signi®cantly from those obtained for trunk cul-
tures grown in EE (P  .05 by the Mann±Whitney U test).
FIG. 4. Effect of HN-1 CM on the percentages of cells in trunk
neural crest cultures that expressed melanin, ®bronectin (FN), and
smooth muscle-speci®c actin (SMA). Cultures were grown for a
total of 7 days in either HN-1 CM or control medium (Ep CM)®bronectin, smooth muscle actin, and melanin. In con¯u-
prior to ®xation and immunocytochemistry. The percentages ofent neural crest cultures, like that shown in Fig. 2, most of
cells expressing each marker were determined relative to the totalthe ®bronectin immunoreactivity is found in the form of
number of DAPI-positive nuclei. At least 600 cells from each of
extracellular ®brils. Thus, it is not possible to determine six cultures grown under each condition were counted. The bars
percentages of ®bronectin-immunoreactive cells using con- show the means { SEM. The asterisks indicate cases in which
¯uent cultures. To circumvent this problem, the neural values obtained for HN-1 CM-treated cultures differed signi®cantly
crest cells were dissociated from the ®lters and replated at from those obtained for Ep CM-treated cultures (P  .002 by the
Mann±Whitney U test).subcon¯uent density 24 hr prior to ®xation. This replating
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TGF-b1 has effects on trunk neural crest differentiation
similar to those produced by young Hensen's node cells
and HN-1 cells. That is, TGF-b1 stimulates ®bronectin and
smooth muscle actin expression and inhibits melanin ex-
pression (Rogers et al., 1992; Leblanc et al., 1995; and un-
published data). These observations raised the possibility
that the active factor in HN-1 CM is a TGF-b. Consistent
with that possibility, RNase protection assays demon-
strated that HN-1 cells express transcripts for TGF-b2 and
3, and Western blots indicated the presence of latent TGF-
b protein in HN-1 CM (data not shown).
To directly test the possibility that the ®bronectin-stimulat-
ing activity in HN-1 CM was a TGF-b, we asked whether the
activity could be immunoprecipitated with a TGF-b antise-
rum. The antiserum used for these experiments (and for the
Western blots mentioned above) was a pan-speci®c antiserum
(R&D Systems) that recognizes at least four TGF-b family
members: TGF-b1, b2, b3, and b5. The CM was incubated
with either this antiserum or a control antiserum (anti-des-
min), and any immune complexes that formed were removed
FIG. 5. Effect of varying lengths of exposure to HN-1 CM on before adding the CM to the cultures. To test the ef®cacy of
®bronectin immunoreactivity (FN-IR) in trunk neural crest cul- the immunoclearance procedure, we added the TGF-b antise-
tures. Cultures were grown for a total of 5 days. During this time rum to control medium (Ep694 CM) supplemented with exog-they were exposed to HN-1 CM for Days 0 to 1, 0 to 3, or 0 to 5.
enous TGF-b1. In these experiments, the TGF-b antiserumLevels of ®bronectin immunoreactivity were then determined by
blocked 78% of the ®bronectin-stimulating activity of 5 ng/ELISA. Values are expressed as fold increase relative to cultures
ml TGF-b1 (Fig. 6A). In contrast, the antiserum did not sig-grown in control medium (Ep CM) for the entire culture period.
ni®cantly affect the ®bronectin-stimulating activity of HN-1Each bar is the mean { SEM of seven determinations. Asterisks
CM. These results suggest that HN-1 CM does not containindicate values that differed signi®cantly from those obtained for
active TGF-b in quantities suf®cient to account for the ®bro-cultures grown in control medium for the entire culture period (P
 .002 by the Mann±Whitney U test). nectin-stimulating activity of the CM. Thus, this activity
must be due to a factor other than TGF-b.
Inhibition of Fibronectin Expression by DirectBecause the HN-1 cell line was isolated as a colony of
Addition of TGF-b Antiserum to Trunk Neuralcells from a mass culture, we could not be sure that the
Crest Culturescell line was clonal. A clonal cell line was subsequently
generated from the HN-1 cell line, and medium conditioned Previous work suggests that endogenous TGF-b's are re-
quired for the development of ®bronectin expression in cra-by this cell line showed ®bronectin-stimulating activity
similar to that of HN-1 CM (data not shown). This observa-
tion suggests that the expression of ®bronectin-stimulating
activity does not require interactions between multiple sub- TABLE 1
populations of node-derived cells. It should be borne in Effect of Trypsin Treatment on the Fibronectin-Stimulating
mind, however, that individual node cells have the capacity Activity of HN-1 CM
to generate several different tissue types in vivo (Selleck
Total levels of FN-IRand Stern, 1991). Hence, even clonal lines of node cells may
(mOD/min/mg protein)become heterogeneous over time in vitro.
Control 70.6 { 22.3
/ HN-1 CM 188.8 { 9.5The Fibronectin-Stimulating Activity in HN-1 CM / Trypsin-treated HN-1 CM 79.2 { 18.2Is a Protein, but Is Probably Not a TGF-b
Note. HN-1 CM was collected under serum-free conditions andTo learn if the ®bronectin-stimulating activity in HN-1
concentrated 10-fold with a Centricon ®lter. Trypsin treatmentCM was a protein, we tested the activity for sensitivity to
was done by incubating the CM with 200 BAEE units/ml of bovineheat and to trypsin. The activity could be destroyed either
pancreatic trypsin (GIBCO) for 1 hr at 377C. The reaction was
by heating at 1007C for 30 min (data not shown) or by incu- stopped by the addition of soybean trypsin inhibitor (1000 BAEE
bation with trypsin (Table 1). In addition, we found that units/ml; GIBCO), and the medium was diluted 1:10 in enriched
the activity was retained by ®lters with molecular weight growth medium prior to addition to trunk neural crest cultures
cutoffs of £30 kDa. Thus, the active factor in HN-1 CM growing in 96-well plates. Each ®gure is the mean{ standard devia-
tion for determinations on three separate cultures.appears to be a protein of molecular weight 30 kDa.
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originating from the HN-1 cells. Adding the antiserum di-
rectly to the neural crest cells would block function of TGF-
b originating from both the HN-1 cells and the neural crest
cells themselves.
Addition of the TGF-b antiserum directly to the cultures
caused a 41% decrease in the stimulation of ®bronectin
expression produced by HN-1 CM (Fig. 6B). It therefore ap-
pears that the presence of one or more TGF-bs in the culture
system promotes the differentiation of trunk neural crest
cells into the ®bronectin-positive phenotype. Since the
clearance experiments suggest that the source of this TGF-
b is not the HN-1 CM, it seems likely that the TGF-b is
produced by the neural crest cells themselves.
Note that the antiserum inhibited the response to HN-1
CM to a lesser degree than it did the response to exogenous
TGF-b. This difference may be due to differences in the
af®nity of the antiserum for avian versus human isoforms
of TGF-b. Alternatively, in the case of a TGF-b secreted by
the neural crest cells, proximity of the protein to the cells
and/or its binding to extracellular matrix molecules could
reduce the effectiveness of the antiserum. In contrast, TGF-
b added to the medium might be more accessible to the
antiserum.
Clonal Analysis of HN-1 CM Effects on Trunk
Neural Crest Cell Development
Clonal studies were performed to determine if the pheno-
typic changes produced in mass cultures by HN-1 CM re-FIG. 6. Effects of a TGF-b antiserum on the ®bronectin-stimulating
sulted from changes in the phenotypic fates of individualactivity of HN-1 CM. (A) Medium was immunoprecipitated with
neural crest cells. Trunk neural crest cell clones were growneither a control antiserum (anti-desmin) or a pan-speci®c TGF-b neu-
tralizing antiserum. The antiserum was then cleared from the me- in 96-well plates and fed either HN-1 CM or control me-
dium using anti-rabbit IgG derivatized beads before adding the me- dium (Ep 694 CM). After 7 days in culture, the clones were
dium the cultures. Control medium (Ep CM) supplemented with 5 replated at lower density onto Primaria dishes to facilitate
ng/ml TGF-b1 was used to test the ef®ciency of the antiserum in visualization of intracellular ®bronectin immunoreactivity.
precipitating a known concentration of exogenous TGF-b. The bars The clones were grown for an additional 2 days, ®xed, and
show means { SEM of six determinations. The asterisk indicates
examined for ®bronectin immunoreactivity and melanin.that the value obtained for medium cleared with anti-TGF-b differed
Three types of clones were encountered (Fig. 7): mela-signi®cantly from that for medium cleared with anti-desmin (P 
nin-positive/®bronectin-negative (Mel//FN0) clones, in.002 by the Mann±Whitney U test). (B) The same antisera were added
which 90±100% of the cells contained melanin; ®bro-directly to the trunk neural crest cultures for the duration of the
nectin-positive/melanin-negative (FN//Mel0) clones, inculture period. Fibronectin immunoreactivity (FN-IR) was deter-
mined by ELISA and expressed as fold increase relative to cultures which 75±100% of the cells contained ®bronectin immu-
grown in control medium (Ep CM). The bars show means { SEM of noreactivity; and melanin-positive/®bronectin-positive
three determinations. The asterisk indicates that the values obtained (Mel//FN/) clones, which contained cells of both pheno-
for anti-TGF-b-treated cultures differed signi®cantly from those ob- types. There were other, unidenti®able, cells in all three
tained for anti-desmin-treated cultures (P  .05 by the Mann±Whit- clone types, and these were most prevalent in the Mel//
ney U test).
FN/ clones. These cells were not neurons; in two sets of
clones examined for neuro®lament immunoreactivity, no
immunoreactive cells were encountered. Thus, these
cells may have been undifferentiated cells that wouldnial neural crest cells (Leblanc et al., 1995). It was therefore
of interest to learn if the same was true for trunk neural have begun expressing either melanin or ®bronectin if
allowed to develop longer.crest cells treated with HN-1 CM. To test this possibility,
TGF-b antiserum was added directly to trunk neural crest Treatment with HN-1 CM caused a twofold increase in
the number of FN//Mel0 clones, and a fourfold decreasecultures during their treatment with HN-1 CM. This experi-
ment differs from the clearance experiment described in the number of Mel//FN0 clones (Fig. 8 and Table 2).
There was no signi®cant change in the number of mixedabove, which was designed to block only the TGF-b activity
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FIG. 7. Three different kinds of trunk neural crest cell clones. (a) A melanin//®bronectin0 clone viewed under UV ¯uorescence superim-
posed on bright-®eld to visualize DAPI staining. (b) A ®bronectin//melanin0 clone viewed with a ¯uorescein ®lter to visualize FN
immunoreactivity. (c) A melanin//®bronectin/ mixed clone viewed under UV superimposed on bright-®eld to visualize DAPI staining.
(d) The same ®eld as shown in (c), viewed with a ¯uorescein ®lter to visualize ®bronectin immunoreactivity. The small solid arrows
point to ®bronectin-positive cells, while the larger open arrow points to a melanin-positive sister cell. Note that only a portion of each
clone is shown in each micrograph. Original magni®cation, 2501.
clones. However, the percentage of cells in the mixed clones sets of conditions. The clones were allowed to grow for an
additional 4 days before ®xation. If HN-1 CM promotedthat expressed ®bronectin was higher for the HN-1 CM-
treated group (22.0 { 6.6% for HN-1 CM-treated versus 8.5 the survival of cells destined to be ®bronectin-positive, one
would expect the number of clones surviving to be lower{ 2.2% for Ep694 CM-treated; mean { SEM for four sepa-
rate experiments) and the percentage of melanocytes was for the group switched to Ep694 CM than for the group
maintained in HN-1 CM. (Note that this experiment is de-lower (34.5 { 4.6% for HN-1 CM-treated versus 61.2 {
14.9% for Ep694-treated). signed with the assumption that the cells have chosen a
particular fate by Day 4 in vitro. Consistent with this idea,HN-1 CM treatment had no signi®cant effect on the sizes
of any of the clone types (Table 2), suggesting that it did not daily observations of the clones generated in previous exper-
iments had shown that many cells that would ultimatelyaffect the proliferation of either melanocyte or ®bronectin-
positive cell precursors. The total number of clones surviv- be ®bronectin-positive had already assumed a ¯attened, ®-
broblastic morphology by Day 4, whereas cells that woulding was likewise unaffected by HN-1 CM. This observation
suggested that HN-1 CM did not act by selectively promot- be melanin-positive tended to be smaller and more spindle-
shaped).ing the survival of ®bronectin-positive cells relative to mel-
anocytes. To test this conclusion further, the following ex- We observed no difference in the viability of clones
treated with one CM for the entire period versus thoseperiment was performed. Clones were grown for 4 days in
either HN-1 CM or Ep694 CM. Half of each group of clones switched at 4 days. Clones treated with HN-1 CM for 8
days and those switched to Ep694 CM on Day 4 showedwas then switched to the other CM, thereby generating four
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act either by promoting the survival of ®bronectin-positive
cells or by inhibiting the survival of melanocytes.
Perhaps the most striking result of this experiment was
that it generated a population of cells expressing a novel
phenotype. These cells contained both intracellular FN im-
munoreactivity and melanin granules (Fig. 9). Some of these
cells exhibited the spindle-shaped or stellate morphologies
typical of melanocytes (Figs. 9a and 9b), while others were
®broblastic in morphology (Figs. 9c and 9d). These cells of
mixed phenotype were seen in two of the clones that had
been switched from HN-1 CM to Ep694 CM, and they con-
stituted approximately 5% of the total cells in these clones.
These results indicate that at least some trunk neural crest
cells have the capacity to express both the melanin- and
®bronectin-positive phenotypes simultaneously.
DISCUSSION
FIG. 8. Effect of HN-1 CM on the percentages of trunk neural
Immortalization of Avian Hensen's Node Cellscrest clones expressing different phenotypes. Clones were grown
for a total of 9 days in either HN-1 CM or control medium (Ep We have used a calcium phosphate transfection procedure
CM). All cells in a total of 42 clones surviving under each condition to immortalize avian Hensen's node cells. In the experiment
were counted. The bars show the means { SEM of percentages
which generated the HN-1 cell line, approximately 25,000obtained in four separate experiments. The asterisks indicate cases
to 50,000 cells were used. The transfection produced twoin which values obtained for HN-1 CM-treated cultures differed
obvious foci of cells (which may or may not have arisensigni®cantly from those obtained for Ep CM-treated cultures (P 
from different precursors), one of which was successfully.01 by the Mann±Whitney U test).
cloned. Thus, the ef®ciency of stable transfection was no
higher than 1 cell in 25,000, which is considerably lower
than has been obtained using retroviral infection in murine
cells (reviewed in Cepko, 1989). Nevertheless, this tech-the same rates of survival (8 of 12). Clones treated with
Ep694 CM for 8 days and those switched to HN-1 CM on nique proved successful in generating immortalized cell
lines from both Hensen's node and epiblast cells.Day 4 also showed the same survival (7 of 10). These results
are consistent with the conclusion that HN-1 CM did not The HN-1 cells show morphological and immunocyto-
TABLE 2
Effects of HN-1 CM on Trunk Neural Crest Clone Type and Size
Total FN//Mel0 Mel//FN0 Mel//FN/ Nonviable
Number of clones
Ep CM 56 11 21 10 14
HN-1 CM 56 24 5 13 14
Clone size
Ep CM 314 { 69 87 { 24 423 { 186 477 { 153
HN-1 CM 336 { 75 88 { 10 403 { 90 906 { 308
Clone size range
Ep-CM 2±1983 2±479 3±1983 53±1283
HN-1 CM 2±2035 2±375 135±590 46±2035
Note. Trunk neural crest cell clones were grown in 96-well dishes in the presence of either Ep694 CM (Ep CM) or HN-1 CM. After 7
days they were replated, ®xed, and examined for melanin granules and ®bronectin immunoreactivity. Three types of clones were found:
®bronectin-positive/melanin-negative (FN//Mel0) clones, which had 75±100% ®bronectin-positive cells and no melanin-positive cells;
melanin-positive/®bronectin-negative (Mel//FN0) clones, which had 90±100% melanocytes; and mixed clones (Mel//FN/), which had
both melanin-positive cells and ®bronectin-positive cells. The values for clone size are shown as the means { SEM of determinations for
42 viable clones grown under each condition.
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FIG. 9. Simultaneous expression of melanin granules and ®bronectin immunoreactivity in cloned trunk neural crest cells. Fibronectin
immunoreactivity (a and c) was viewed under epi¯uorescence using a ¯uorescein ®lter. Melanin granules were viewed under either bright-
®eld (b) or epi¯uorescence using a UV ®lter (d). These cells are from clonal cultures that were grown for 4 days in HN-1 CM and then
switched to Ep694 CM for 4 days. (a and b) The long arrow points to a cell containing both ®bronectin immunoreactivity (a) and melanin
granules (b). The short arrows point to cells positive for melanin (b) and negative for ®bronectin (a). (c and d) A large cell with ®broblastic
morphology containing ®bronectin immunoreactivity. DAPI staining (d) shows that the cell has two nuclei, as is frequently true of the
®bronectin-immunoreactive cells (but not the melanocytes) in these cultures. However, the cytoplasm of this cell is also densely packed
with melanin granules. Original magni®cation, 2461.
chemical similarities to the prospective mesodermal cells phenotypes in trunk neural crest cells (Leblanc and Holbert,
of Hensen's node. In addition, the immortalized cells do not 1996). This activity is both spatially and temporally re-
express markers characteristic of fully differentiated deriva- stricted: it is present in the node but absent from the ante-
tives of the node, such as notochord or skeletal muscle. rior epiblast of stage 4 embryos, and it disappears from the
These observations suggest that the immortalization proce- node by stage 8 (Leblanc and Holbert, 1996). Similar spatial
dure has arrested the cells in a developmentally immature, and temporal speci®cities have been observed for the capac-
actively proliferative state. The HN-1 cells therefore may ity of the node to induce anterior neural tube phenotypes
be useful for isolation of inductive factors that are normally (Waddington, 1932; Tsung et al., 1965; Vakaet, 1965; Gal-
produced by Hensen's node in vivo. lera, 1970; Storey et al., 1992). These observations are con-
sistent with the possibility that Hensen's node directs the
A-P regionalization of the neural crest together with that
HN-1 Cells Secrete a Neural Crest Differentiation of the neural tube during normal development in vivo.
Factor Our current results show that immortalized cells derived
from Hensen's node retain the ability to regulate region-In previous work, it was shown that young (stage 4)
Hensen's node can act in vitro to stimulate cranial-speci®c speci®c phenotypes in trunk neural crest cells. Like primary
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Hensen's node cells, the HN-1 cells stimulate the expres- TGF-b originates from the neural crest cells rather than
from the HN-1 CM. Consistent with this possibility, previ-sion of ®bronectin and smooth muscle actin in trunk neural
crest cultures and inhibit the expression of melanin. The ous work has shown that both cranial and trunk neural
crest cells secrete TGF-b in vitro (Brauer and Yee, 1993;phenotype-regulating activity of the HN-1 cells can cross a
Millipore ®lter, suggesting that it is diffusible. Consistent Leblanc and Holbert, unpublished results). In addition,
treatment of cranial neural crest cultures with TGF-b anti-with that idea, we found that the activity is present in HN-
1 cell-conditioned medium. Thus, the HN-1 CM can be serum has been shown to inhibit the development of ®bro-
nectin expression in these cultures (Leblanc et al., 1995).used as a source for further characterization of the activity.
It should be noted that ®bronectin, smooth muscle actin, The latter ®nding is consistent with the idea that TGF-b
acts in an autocrine manner to promote the developmentand melanin have certain limitations as markers of region-
speci®c neural crest cell differentiation. First, they are ex- of ®bronectin expression in cranial neural crest cells, and
therefore also may do so in trunk neural crest cells treatedpressed relatively late in neural crest development. Second,
while ®bronectin and smooth muscle actin are expressed with HN-1 CM.
preferentially in cranial cultures, they are also expressed at
low levels in trunk cultures. Similarly, melanin expression
Clonal Analysis of Trunk Neural Crest Cellsis not limited exclusively to trunk cultures, but occurs at
low levels in cranial cultures as well. Lack of complete There are three different mechanisms that could explain
the phenotypic changes produced by HN-1 CM treatment inregional speci®city in the expression of these three markers
is seen in vivo as well as in vitro. Trunk neural crest cells mass cultures of trunk neural crest. First, HN-1 CM might
instruct individual cells that would normally become mela-are capable of generating limited amounts of connective
tissue and smooth muscle following transplantation to the nin-positive to adopt a ®bronectin-positive fate instead. Al-
ternatively, HN-1 CM might selectively promote the prolif-cranial or vagal regions (Nakamura and Ayer-Le Lievre,
1982; Kirby, 1989), and studies in mouse suggest that cranial eration of ®bronectin-positive cell precursors and/or inhibit
the proliferation of melanocyte precursors. Finally, HN-1neural crest cells normally contribute to the melanocyte
population of the head (Steel et al., 1992; Wehrle-Haller and CM might increase the survival of ®bronectin-positive cell
precursors relative to melanin-positive cell precursors.Weston, 1995). The fact that these markers are expressed
with less than perfect regional speci®city raises the possibil- Clonal analysis was used to distinguish among these possi-
bilities.ity that their expression may be regulated by factors other
than those involved in the regionalization of the neural The data presented here support the conclusion that the
effects of HN-1 CM on trunk neural crest cells are instruc-crest. Thus, while these markers are convenient to assay,
it will be important to examine the effects of HN-1 CM on tive. First, we found that treatment with HN-1 CM in-
creased the percentage of FN//Mel0 clones and decreasedother markers, such as homeobox genes, whose distribution
within the neural crest is more strictly regionalized. the percentage of Mel0/FN/ clones. In addition, HN-1 CM-
treated mixed clones contained a higher percentage of ®-
bronectin-positive cells and a lower percentage of melanin-
Is the HN-1 CM Factor a TGF-b Family Member? positive cells than did mixed clones grown in control me-
dium. Finally, the possibility that the CM is instructiveSome of the effects of HN-1 CM on trunk neural crest
differentiation are mimicked by TGF-b1 (Rogers et al., requires that the target precursor cell be multipotent. Previ-
ous clonal analyses have shown that individual trunk neural1992; Leblanc et al., 1995). This observation raised the pos-
sibility that the active factor in HN-1 CM is a TGF-b mole- crest cells can give rise to multiple derivatives, including
melanocytes and neurons (Cohen and Konigsberg, 1975;cule. In this study, we found that HN-1 CM retains its
®bronectin-stimulating activity after clearance with a TGF- Bronner-Fraser and Fraser, 1988; Sieber-Blum, 1989). It has
also been shown that individual cranial neural crest cellsb antiserum. It therefore seems unlikely that the activity
in the HN-1 CM is due to a TGF-b. However, we have not can produce both melanocytes and mesenchymal deriva-
tives (Barof®o et al., 1991; Ito and Sieber-Blum, 1991), butexcluded the possibility that the activity is due to a more
distantly related member of the TGF-b superfamily, such the same has not been demonstrated previously for trunk
neural crest. In the present study, we showed that trunkas a bone morphogenetic protein, dorsalin, or nodal. Activin
A does not appear to be a candidate factor, since it does neural crest cells can generate clones containing both mela-
nocytes and ®bronectin-positive cells. Indeed, under somenot stimulate ®bronectin expression in trunk neural crest
cultures (Leblanc et al., 1995). culture conditions trunk neural crest cells can express both
melanin and ®bronectin simultaneously. These results indi-The results of the immunoclearance experiment contrast
with those obtained when the TGF-b antiserum was applied cate that bipotent melanocyte/mesenchymal cell precursors
are present in the trunk region as well as the cranial regiondirectly to the HN-1 CM-treated cells. In the latter case, a
substantial reduction in ®bronectin expression was seen. of the neural crest.
The present data also argue against selective effects ofThese data suggest that a TGF-b is required for the induc-
tion of ®bronectin expression by HN-1 CM, but that this HN-1 CM on cell proliferation or viability. HN-1 CM had
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Bronner-Fraser, M., and Fraser, S. (1988). Cell lineage analysisno signi®cant effect on the sizes of any of the clone types,
shows multipotentiality of some avian neural crest cells. Naturesuggesting that it does not affect the proliferation of either
335, 161±164.®bronectin-positive or melanin-positive cells precursors.
Canning, D. R., and Stern, C. D. (1988). Changes in the expressionHN-1 CM also appears to have no selective effect on the
of the carbohydrate epitope HNK-1 associated with mesodermsurvival of either cell type, since overall clone viability was
induction in the chick embryo. Development 104, 643±655.
the same for clones grown in HN-1 CM and Ep694 CM. Cepko, C. L. (1989). Immortalization of neural cells via retrovirus-
Moreover, switching the clones from one CM to the other mediated oncogene transduction. Annu. Rev. Neurosci. 12, 47±
at a critical time in their development did not affect their 66.
viability. Together, these data suggest that the HN-1 CM Chomczynski, P., and Sacchi, N. (1987). Single step method of RNA
is not acting on cell proliferation or survival, but rather is isolation by acid guanidinium thiocyanate-phenol-chloroform
extraction. Anal. Biochem. 162, 156±159.causing individual cells to adopt one potential fate (®bro-
Cohen, A. M. (1977). Independent expression of the adrenergic phe-nectin-positive) over another (melanin-positive) with
notype by neural crest cells in vitro. Proc. Natl. Acad. Sci. USAgreater frequency.
74, 2899±2903.
Cohen, A. M., and Konigsberg, I. R. (1975). A clonal approach to
the problem of neural crest determination. Dev. Biol. 46, 262±Conclusions
280.
We have demonstrated that an activity secreted by an Gallera, J. (1970). Inductions ceÂreÂbrales et meÂdullaires chez les
immortalized Hensen's node cell line, HN-1, regulates the Oiseaux. Experientia 26, 885±886.
expression of region-speci®c phenotypes in trunk neural Hamburger, V., and Hamilton, H. L. (1951). A series of normal
crest cells. In this respect, the HN-1 cells behave similarly stages in the development of the chick embryo. J. Morphol. 88,
49±92.to primary young Hensen's node cells. The HN-1 CM factor
Hammond, W. S., and Yntema, C. L. (1964). Depletions of pharyn-is not precipitated with a TGF-b antiserum and is therefore
geal arch cartilages following extirpation of cranial neural crestunlikely to be a TGF-b isoform. However, direct blocking
in chick embryos. Acta Anat. 56, 21±34.studies suggest that the HN-1 CM factor requires the down-
Horstadius, S. (1950). ``The Neural Crest: Its Properties and Deriva-stream activity of neural crest cell-derived TGF-bs. Clonal
tives in the Light of Experimental Research.'' Oxford Univ. Press,studies suggest that the HN-1 CM factor does not selec-
New York.
tively affect the survival or proliferation of either ®bronect- Howard, M. J., and Bronner-Fraser, M. (1985). The in¯uence of neu-
in- or melanin-positive cell precursors. Instead, we provide ral tube-derived factors on differentiation of neural crest cells in
evidence that the HN-1 CM factor directs the differentia- vitro. I. Histochemical study on the appearance of adrenergic
tion of multipotent precursor cells away from the melanin- cells. J. Neurosci. 5, 3302±3309.
positive phenotype and towards the ®bronectin-positive Ito, K., and Sieber-Blum, M. (1991). In vitro clonal analysis of quail
cardiac neural crest development. Dev. Biol. 148, 95±106.phenotype.
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